Skip to main content

C-40000

NCT03653091

C-40000

Associated Conditions

Type 2 Diabetes

Principal Investigator

Sponsor

Fractyl Laboratories

Study Purpose: The purpose of this study is to learn more about the use of the RevitaTM System for the treatment of Type 2 diabetes.

To be enrolled in this study, you must meet certain requirements. You may be eligible to participate if you meet the following criteria:

Study Duration: up to 60 weeks

Study Commitment:
•    3 Screening visits
•    Up to 11 Outpatient visits (including procedure visit)
•    Up to 10 Phone calls 

Age: 28-65 years old
 
Sex: Male & Female
 
Conditions/Eligibility:
•     BMI 28-40 kg/m2
•    Type II Diabetes (at least three years)
•    Prescribed with 2 OADs, one of them metformin
 
Study Procedures:
•    Physical exam, vital signs, height, and weight, EKG, fasting labs
•    IV insertion
•    Multiple blood draws
•    Phone calls
•    Urine Screen
•    Pregnancy Test
•    MRI

Compensation: offered up to $2,325

Please call (407) 303-7193 or fill out the Contact Form below for more information.

This study is currently enrolling.